Many of our pioneering systems are designed to exceed HTA criteria
Many of our pioneering systems are designed to exceed HTA criteria
BioVault has achieved a number of accreditations and forged relationships with numerous bodies since 2002, all designed to test the robustness of our internal procedures and reassure clients they are being given the highest levels of quality and service.
Many of BioVault's pioneering systems have been designed to exceed the criteria set out by the Human Tissue Authority (HTA) with whom we work closely. The HTA is the competent authority under the European Tissue and Cell Directive and sets the standards for regulating human tissue application establishments.
Licences, accreditations and memberships include:
JACIE
BioVault was awarded JACIE accreditation in November 2011, an extremely proud achievement for us as we are the first private tissue bank to be awarded this accreditation in the UK. JACIE The Joint Accreditation Committee-ISCT & EBMT is a non profit body established in 1998 for the purposes of assessment and accreditation in the field of haematopoietic stem cell (HSC) transplantation.
HTA
BioVault holds an open ended, unconditional HTA licence which covers every aspect of all transplantable material for human application. For more detail concerning BioVault's HTA licence, click here.
(licence no: 11063)
ISO 9001
The internationally recognised standard for an organisation's internal Quality Management.
(certificate no: GB04/62552)
ISO 13485
Quality management standards for medical devices
(certificate no: GB07/72849)
NEQAS
BioVault's Flow Cytometers are externally quality controlled by NEQAS .
British Association of Tissue Banks
BioVault is an established member of the British Association of Tissue Banks
ESBB
Biovault has also recently become a member of the ESBB, European, Middle Easter and African Society for Biopreservation and Biobanking. The mission of the ESBB is to advance the field of biobanking in support of research relating to healthcare, education and the environment.
OHIM
Biovault has been issued the Certificate of Registration for the Community Trade Mark as of 24.12.2009 by The Office of Harmonization for the Internal Market. This is valid in all 27 countries of the EU.
BIOVAULT© 2009 PIONEERING STEM CELL & TISSUE BANKING